Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.47 | -19.34 |
PEG Ratio (TTM) | 0.06 | -6.10 |
P/S Ratio (TTM) | 1.60 | 45.38 |
P/B Ratio (TTM) | 0.56 | 29.05 |
P/FCF Ratio (TTM) | -0.52 | -3.91 |
Price to 5YR AVG Earnings Ratio | -0.50 | -6.78 |
Price to 5YR AVG FCF Ratio | -0.68 | -12.87 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -64.28% | -15.28% |
ROE (TTM) | -80.13% | 26.93% |
Net Profit Margin (TTM) | -340.96% | -648.67% |
ROIC 5YR AVG | -69.97% | -8.24% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -42.90% | -9.41% | -0.96% |
Revenue | 196.08% | 78.12% | 101.57% |
Net Income | -42.80% | -23.36% | -11.09% |
Cash Flow | -23.39% | -107.42% | -61.01% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.75 | 5.58 |
Quick Ratio (TTM) | 3.75 | 5.36 |
D/E Ratio (TTM) | 0.09 | 0.98 |
Interest Coverage (TTM) | -65.88 | -6.85 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 12.49 |
LTL to 5YR AVG FCF | -0.17 | 0.08 |
Shares Outstanding Growth 5YR AVG | 10.19% | 37.38% |